First Time Loading...

CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 237 SEK 4.41%
Updated: May 9, 2024
Section:
 

Relative Value

The Relative Value of one CEVI stock under the Base Case scenario is 318.71 SEK. Compared to the current market price of 237 SEK, CellaVision AB is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CEVI Relative Value
Base Case
318.71 SEK
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8
P/S
P/S
Price to Sales
8
vs History
77
vs Industry
18
Median 3Y
9.2
Median 5Y
13.5
Industry
2.4
Forward
7.1
More Details
40
P/E
P/E
Price to Earnings
40
vs History
87
vs Industry
13
Median 3Y
50.3
Median 5Y
64.1
Industry
23.4
Forward
31.9
More Details
22.7
P/OCF
P/OCF
Price to OCF
22.7
vs History
95
vs Industry
20
Median 3Y
43.3
Median 5Y
54.8
Industry
15.5
More Details
44.9
P/FCFE
P/FCFE
Price to FCFE
44.9
vs History
73
vs Industry
14
Median 3Y
106.9
Median 5Y
93
Industry
23.2
More Details
7.5
P/B
P/B
Price to Book Value
7.5
vs History
79
vs Industry
10
Median 3Y
9.3
Median 5Y
15.7
Industry
2.3
More Details
7.8
EV/S
EV/S
Enterprise Value to Sales
7.8
vs History
79
vs Industry
17
Median 3Y
9.1
Median 5Y
13.5
Industry
2.5
Forward
6.9
More Details
11.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.5
vs History
77
vs Industry
20
Median 3Y
13.2
Median 5Y
19.3
Industry
5.3
More Details
30.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
30.5
vs History
80
vs Industry
10
Median 3Y
37.1
Median 5Y
46.3
Industry
12.6
Forward
20.7
More Details
30.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
30.5
vs History
85
vs Industry
15
Median 3Y
37.2
Median 5Y
49.2
Industry
17.2
Forward
24.5
More Details
22.1
EV/OCF
EV/OCF
Enterprise Value to OCF
22.1
vs History
96
vs Industry
21
Median 3Y
43
Median 5Y
53.9
Industry
15.3
More Details
32.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
32.7
vs History
96
vs Industry
17
Median 3Y
72.7
Median 5Y
82.2
Industry
19.8
More Details
7.2
EV/IC
EV/IC
Enterprise Value to IC
7.2
vs History
76
vs Industry
13
Median 3Y
8
Median 5Y
12.1
Industry
2
More Details

Multiples Across Competitors

CEVI Competitors Multiples
CellaVision AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
CellaVision AB
STO:CEVI
5.7B SEK 8 40 30.5 30.5
US
Abbott Laboratories
NYSE:ABT
182.6B USD 4.5 32.4 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
134.9B USD 18.4 67.9 55.7 69.8
US
Stryker Corp
NYSE:SYK
125.4B USD 6 37.3 24.2 29.8
IE
Medtronic PLC
NYSE:MDT
108.4B USD 3.4 25.8 13.7 19.4
US
Boston Scientific Corp
NYSE:BSX
106.9B USD 7.3 60.5 30.5 45.1
US
Becton Dickinson and Co
NYSE:BDX
67.5B USD 3.5 55.4 18.6 39.2
DE
Siemens Healthineers AG
XETRA:SHL
57.9B EUR 2.7 38.2 18.3 30.9
US
Edwards Lifesciences Corp
NYSE:EW
51.2B USD 8.3 36.2 26.3 28.5
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
366B CNY 10.7 32.4 28.1 28.1
US
Dexcom Inc
NASDAQ:DXCM
50.5B USD 13.3 78.9 59 76.8

See Also

Summary
CEVI intrinsic value, competitors valuation, and company profile.
DCF Valuation
CEVI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CEVI stock valuation using valuation multiples.
Wall Street Estimates
CEVI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CEVI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.